PIII vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

PIII

40.4
AI Score
VS
PIII Wins

PACS

38.0
AI Score

Investment Advisor Scores

PIII

40score
Recommendation
HOLD

PACS

38score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric PIII PACS Winner
Forward P/E 0 18.7617 Tie
PEG Ratio 0 1.2502 Tie
Revenue Growth 8.6% 11.5% PACS
Earnings Growth 0.0% 15.6% PACS
Tradestie Score 40.4/100 38.0/100 PIII
Profit Margin -6.6% 4.9% PACS
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY PIII

Relative Price Performance (Last 90 Days)

PIII 1M: -23.9% · 3M: -71.1% PACS 1M: +10.8% · 3M: +8.0%

Current Technical Phase

PIII

Markdown
Sell / avoid

Price below a falling SMA50 (slope -30.7%), weak momentum, RSI 32

RSI (14): 32.4 · Price: $3.38

PACS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.9% over 20 days), RSI 58

RSI (14): 57.6 · Price: $49.10

Fundamentals Snapshot

Metric PIII PACS
Market Cap — —
Forward P/E -0.2 17.5
Trailing P/E — 28.2
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.0% 0.2%
Operating Margin 0.1% 0.1%
EPS -33.02 1.73
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PIII is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.